Medicine
Cefepime 2 g/100 mL injection
Cefepime 2 g/100 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Thaw frozen container at room temperature 25°C (77°F) or under refrigeration…
Key facts
- Active ingredient (INN)
- Cefepime
- Brand
- Sold under the generic name
- Strength
- 2 g/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 12 bags of 100 mL
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Thaw frozen container at room temperature 25°C (77°F) or under refrigeration 5°C (41°F). The thawed solution remains stable for 7 days under refrigeration 5°C (41°F) or 24 hours at room temperature 25°C (77°F). Store at or below –20°C (-4°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DE01 Cefepime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2008
- Identifiers
- RxCUI 1665088, 1665093DailyMed set ID be5f8ca6-7232-423a-a2d5-cccb7abe7921NDC 0338-1301Application NDA050817
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 bag in 1 box / 100 mL in 1 bag | 0338-1301-48 | Baxter Healthcare | 5 August 2008 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 January 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefepime
Clinical summary
Cefepime is a cephalosporin antibacterial indicated in the treatment of infections caused by susceptible isolates of the designated microorganisms, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Cefepime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefepimeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefepime prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Cefepime 2 g/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.